Targeted therapies are designed to attack specific molecules involved in cancer growth and progression. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapies aim at particular genetic mutations or cellular mechanisms unique to cancer cells. Examples include tyrosine kinase inhibitors and monoclonal antibodies. These treatments have shown promising results, particularly in cancers with well-defined molecular targets, such as certain types of breast, lung, and colorectal cancers.
